GSK2656157   Click here for help

GtoPdb Ligand ID: 9544

Synonyms: compound 6 [PMID: 24900593] | GSK-2656157
Compound class: Synthetic organic
Comment: GSK2656157 is an optimised, ATP-competitive inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), designed using the structural scaffold of GSK2606414 [2]. Preclinical evaluation is reported in [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 89.93
Molecular weight 416.18
XLogP 2.77
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(N1CCc2c1ccc(c2F)c1cn(c2c1c(N)ncn2)C)Cc1cccc(n1)C
Isomeric SMILES O=C(N1CCc2c1ccc(c2F)c1cn(c2c1c(N)ncn2)C)Cc1cccc(n1)C
InChI InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27)
InChI Key PRWSIEBRGXYXAJ-UHFFFAOYSA-N
References
1. Atkins C, Liu Q, Minthorn E, Zhang SY, Figueroa DJ, Moss K, Stanley TB, Sanders B, Goetz A, Gaul N et al.. (2013)
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity.
Cancer Res, 73 (6): 1993-2002. [PMID:23333938]
2. Axten JM, Romeril SP, Shu A, Ralph J, Medina JR, Feng Y, Li WH, Grant SW, Heerding DA, Minthorn E et al.. (2013)
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.
ACS Med Chem Lett, 4 (10): 964-8. [PMID:24900593]